Article Submission

Do you have unique insights and perspectives about the application of SGLT-2 inhibitors in clinical practice? If so, we encourage you to submit short articles about the evolving landscape of SGLT-2 inhibitors in T2DM and beyond.  The articles may include original thought pieces, editorials, clinical pearls, case reports and more.  Upon review, articles will be indexed here and in our official publication, Cardiometabolic Chronicle.